Additional file 1 of WDR3 undergoes phase separation to mediate the therapeutic mechanism of Nilotinib against osteosarcoma

Institutions

Publication Details

Journal
Figshare
Published
2025-01-01
DOI
https://doi.org/10.6084/m9.figshare.29551187
Primary Topic
Fibroblast Growth Factor Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Additional file 1 of WDR3 undergoes phase separation to mediate the therapeutic mechanism of Nilotinib against osteosarcoma

Figshare
Fibroblast Growth Factor Research
article

Additional file 1 of WDR3 undergoes phase separation to mediate the therapeutic mechanism of Nilotinib against osteosarcoma

article en

Abstract

No abstract available for this paper.
Figshare
Sheng Jing Hospital (CN), Liaoning Cancer Hospital & Institute (CN), Yangzhou University (CN)
Zero hunger
Openalex Percentile: Top 61%
Fibroblast Growth Factor Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Additional file 1 of WDR3 undergoes phase separation to mediate the therapeutic mechanism of Nilotinib against osteosarcoma · Figshare (2025) | TGRS Research Map | TGRS